CTT PHARMACEUTICAL HOLDINGS, INC.
CTT Pharmaceuticals improves patients' quality of life by providing safe, flexible, and innovative drug delivery systems. They offer patented micelle thin-film technology for faster oral drug delivery, including vitamins and nicotine oral strips, aiming for manufacturing in 2026. The company is focusing on becoming SEC reporting to increase transparency.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
NEXGEL, INC.
NEXGEL specializes in advanced hydrogel solutions, producing skin-friendly patches with high water content, ideal for transdermal delivery of OTC medications and cosmetic ingredients. Their unique electron-beam cross-linking process ensures gentleness and superior skin compatibility compared to traditional adhesive patches. They cater to both large pharmaceutical companies and cosmetic startups seeking innovative delivery systems. Based in Pennsylvania, NEXGEL has over two decades of experience formulating gentle and effective hydrogel patches.
Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic drugs for rare and orphan diseases. They have a pipeline targeting various rare indications, including Netherton Syndrome. They plan to establish sales infrastructure in the US, Europe, and Japan and have marketing partnerships in 60 countries. They aim to bring hope to patients with unmet medical needs.
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. Their lead drug candidate, TPI 287, is an abeotaxane. The company focuses on aggressive brain cancers like glioblastoma multiforme (GBM). They aim to improve patient outcomes through pioneering research and transformative therapies.